سعر انفكتودينت 10 اقراص 250/366 مجم 2024

Infectodent film-coated tablets (10, labelled 250/366 mg): fixed combination of metronidazole and spiramycin listed in Egypt under Mash Premiere for dental and oral infections.

• Curative treatment of odonto-stomatological infections (acute, chronic or recurrent), e.g. dental abscess, cellulitis, pericoronitis, gingivitis, stomatitis, parotitis, submaxillitis, when another antibiotic cannot be used; prevention of local postoperative infection after oral surgery.Population: Adults and children 6 years and olderANSM (Agence nationale de sécurité du médicament), France

• Spiramycin: gastrointestinal upset, rash, transient paraesthesia, dysgeusia, QT prolongation. Metronidazole: peripheral neuropathy, headache, vertigo, convulsions, encephalopathy, gastrointestinal effects, metallic taste.General active-ingredient information · ANSM (Agence nationale de sécurité du médicament), France

• Hypersensitivity to spiramycin, metronidazole, imidazole derivatives or any excipient; children under 6 years (tablet form).General active-ingredient information · ANSM (Agence nationale de sécurité du médicament), France

• Anaphylactic reactions and severe cutaneous reactions (Stevens-Johnson syndrome, Lyell syndrome, acute generalised exanthematous pustulosis): stop treatment.General active-ingredient information · ANSM (Agence nationale de sécurité du médicament), France
• Metronidazole: encephalopathy, cerebellar syndrome, peripheral neuropathy and psychotic reactions reported; stop treatment if neurological signs occur; monitor blood counts with prolonged or repeated use.General active-ingredient information · ANSM (Agence nationale de sécurité du médicament), France
• Spiramycin: QT prolongation reported; caution in patients with risk factors.General active-ingredient information · ANSM (Agence nationale de sécurité du médicament), France

• AlcoholDisulfiram-like (antabuse) reaction with metronidazole; avoid alcohol.ANSM (Agence nationale de sécurité du médicament), France
• DisulfiramRisk of delirium and confusion; combination not recommended.ANSM (Agence nationale de sécurité du médicament), France
• BusulfanMetronidazole increases busulfan toxicity; combination not recommended.ANSM (Agence nationale de sécurité du médicament), France

• French SmPC: use may be considered during pregnancy if needed.General active-ingredient information · ANSM (Agence nationale de sécurité du médicament), France
• French SmPC: avoid breastfeeding (both substances pass into milk).General active-ingredient information · ANSM (Agence nationale de sécurité du médicament), France

English text not available for this section.